Sp Group A/S

Good afternoon and welcome. On behalf of Hans Christian Andersen Capital, I would like to welcome you to this presentation of the report from the first half of 24 and also the second quarter of 24 from SP Group that was published Friday. My name is Rasmus Koldborg and I have the pleasure of welcoming both the departing CEO of SP Group, that's Frank Gell. We have the coming CEO of SP Group, Lars Bering, and we have the CFO of SP Group, Tilde Keilhoff. promise to take us through the numbers and highlights from the courses and expectations going into the further part of 2024 and of course also ask questions or answer questions sorry so welcome to you and also welcome to those of you who signed up for today's presentation you can ask questions in the chat even i either ask them in english or you can also do it in danish and we'll help with the translation but with that i'll leave the floor to the three of you

Thank you, and thank you for joining us for this presentation. We have had a good first quarter and an excellent second quarter, so we are back on the growth track on the top line. We have sold more of our proprietary products, and we have improved the bottom line. The group management looks, as you can see here on the picture, with the three of us. Anson Ullstrup is busy with our customers today, and then you can take the next one. And I have decided to step down as CEO from September 1st. And the board has appointed Lars Behring as my successor. So Lars will be the CEO from 1st of September until he has been appointed to the executive board and as the CFO. And Tilda and Lars and Søren and I have been executive board now for four years, and we have worked very well together. And I'm leaving, so the three other team members will continue under Lars' leadership. Take the next one. And why now? Well, I'm turning 64 in September, and I've been the CEO for SP Group for 20 years. SP Group is back on the growth track, and we have a healthy economy. Lars is ready to take over and the team Larsson and Tilde has worked well together for the past four years and can run without me. And we are well on the way to fulfilling our 2024 ambitions, which we will highlight during the presentation here. Next. So this is a new management and you can take the next. And we are now, we established now in 72. We have sold our products and services in 98 countries last year, and we have subsidiaries in 12 countries at three continents. So we are in North America, in Europe, and in Asia, and we are 2,351 committed employees. Take the next one. We make surface solutions and plastic solutions, and approximately 30% of our business is proprietary product where we sell our own products, and 70% is subcontracting work. We call it customer-specific solutions. We have added two new names to this slide since our latest presentation, and that is SP Molding Inc. in Atlanta, and it is SP Meditech Inc. in Atlanta. We'll come back to that a little later. Take the next one. And the next one. We have in the first half of this year increased the top line with 8.4%. It was a lower growth in the first quarter, higher growth in the second quarter, and it was the third quarter in a row where we're back on the growth track. We have sold many more of our proprietary products. So OM Brands is up with 38% and is now 438 million. Epida increased with 31.2% to 302 million. and EBITDA margin improved 3.5 percentage points to 20.3. And the huge improvement in the EBITDA margin and in the EBIT is thanks to the high growth in proprietary products. Next one. We have made a profit before tax of 176 million. That is 63% more than the same period last year. Earnings per share is also up with 63%. We have reduced the net interest paying debt with 107 million. So it is now 924 million. And we have increased the equity with 112.5 million to 1,576,000. And this is after we have paid 36 million in dividend. We have decided now to launch a new share buyback program and that will start today and run until April 10 in 2025. And we'll buy shares back for 40 million to each of our one programs. Take the next one. This is some of our own products. This is fenders and floats. We sell to fishermen around the world and also to people who has a sailing boat or a motorboat. Take the next one. Here you can see we have become a bigger company, a more profitable company with a stronger balance sheet over the years. And we will go into details on the next slide. This is the top line growth. And here you can see we're back on the growth track now in the first half of this year with 8.4%. And historically, we have been able to grow around 10% since 2010. And in the second quarter, we were actually growing 15%. Next one. This year is the EBITDA and the EBITDA is up with more than 30 percent in the first half of this year. And we are now back on the growth curve again here after we had a slow 2023 where interest rates went up and our customers was focusing very much on the working capital to reduce the inventory level. And that gave us a little Decrease in the sales and we have been planning for growth. So we have invested in people and equipment and therefore APM went down. But I'm happy that we are back on track now on the way up. But you can see we have also in the past seen a couple of times a slowdown and then we came back on track. Next one. This is the EBITDA margin, and this is 12 months, last 12 months, and there we are around 19. But in the last two quarters, we are around 20. And that is a nice improvement over the last decade from a level around 10%. And this is mainly thanks to the higher focus on proprietary products that now consist of 30% of the sales, up from less than 15% a decade ago, but also because we have invested a lot of money in new equipment, new technologies, launched new products, and invested heavily to become much more international. Next one. And the EBT is also doing up again after a downturn last year. We were surprised by the high interest rates that took money away from the bottom line. We are now on the way back. And I'm pretty convinced that during the next quarters, we will surpass the previous all-time high. And looking back here, then in 2010, we made 25 million in profit. And that was the highest ever. And we made a plan to double that to 50 within five years. Then we reached that. Then we made a plan to double that within five years to 100. Then we did that. Then we made a plan to reach 200 within five years. Then we did that. And now we are chasing a plan to reach 400 soon. And after a difficult 23, then we are back and we are getting closer. Take the next one. We have reduced the gearing so the net interest is down to 1.8 and we expect we will be around 1.5 at the end of the year and this is taking into consideration that we continue to invest in new equipment and we will also start this share buyback program and in the first half of this year we have completed the building of what is going to become a new factory in Atlanta in the United States. So we get more presence in the very important North American healthcare market, but also for injection molding for technical applications. Next one. Group financials, you can see we had an excellent second quarter. We had also a good first quarter. So in the first half, top line is up with 8.4%. EBITDA is up with 31.2%. EBIT is up with 56%. And profit before tax is up with 63.5%. And the equity is up with 12.9%. And if you go to the bottom, then you can see equity ratio is 49.9 up from 45.7 12 months ago. We've had a strong cash flow from operations. We have continued to invest in the future and we have repaid debt and paid dividend. And this year is proprietary products. And then we had a dip last year and now you can see we're back on track. So we follow now the nice development in the curbs from first half of 2020, 21, 22 and now 24. And we are growing in more or less all the own product brands and all the different product lines. So we are selling more ergonomics, we are selling more animal housing, ventilation, more guide bars, more medical packaging, and more industrial standard components. Next one. And we have increased the revenue from the cleantech industry, from the healthcare industry, but then we've seen a decline in other demanding industries and a small increase in the food-related industries. Next one. And you can see there is quite a lot of dynamics here. So where we last year had a decline in health care, then we had a very strong growth in health care this year. We have continued growth in cleantech after also a strong 23. The food related is back on track and growing. Then, however, automotive has slowed down. So we are minus 30% here compared to last year. All the mining industries is down with 17%, and the own brands is up with 38%. One of the own brands where we are very successful is Clear Vials, produced by Medico Park. And the lady here on the picture is doing visual inspection of the Clear Vials. And the Clear Vials is used for medicine to people, and it has been growing very, very fast. in the first half of this year, and we hope this growth can continue. And the FDA has told a number of drug makers that for some applications, glass is not good. They have to use plastic. And we are very happy that we then have an application that is ready for use. Next one. 40% of the revenue in the first half came from healthcare. 29% from cleantech, 12% from food-related, 4% from automotive, and 15% from all our demanding industries. And we have more than 1,000 customers. We have one customer that is more than 10% of sales. And the 10 largest customers are 46%. The 20 largest are 56%. Next one. And we have all these plants here around the world. We will soon open the new one in Atlanta in the United States. Now we have one in Ohio. One in, and one in Iowa. And then we have two in China, one in Bangkok, in Thailand, two in Finland. And then we are in Sweden, Poland, Latvia, Slovakia, Denmark. And then we have sales offices that is the red dots in Canada, Norway and the Netherlands and in Sweden. Next one. We have made a number of acquisitions during the last decades. We have not made acquisitions in 23 and in 24 because we have not been able to find good companies that fit in and where we could buy them at an attractive price. But the companies we have bought between 14 and 22, we're very happy with. They have contributed with new customers, new technology, a more global footprint. A number of good and exciting colleagues proving what we had and what we have got. And we can now offer much more to our customers in terms of competences and local presence around the world. Next one. And here you can see we have generated 75% of our sales in the first half outside Denmark that is in line with our 24 ambition. 30% of that is coming from our own product that is also in line with our aim of 28 to 30%. We have now 70% of the employees outside Denmark And we are in the phase of hiring in North America for our new plant. And we have 17 plants around the world outside Denmark and 14 in Denmark. So we have 31 now. And then we will, during the second half of this year, open in Atlanta. And that will take us to 32 plants globally. Without making further acquisitions. And of course, we are still open for that. Next one. Our share price has improved a little in the first half of this year, but we have not been able to follow the market during 2022, 2023 and 2024. We did pretty well until the end of 2021, but when the interest rates went up, then that hit our valuation, but we have also to admit that the decline in the sales and in the profit in 2023 of course also have affected the share price. But now we are back on the growth track on the top line and on the bottom line and hopefully interest rates will soon come down again and our share price will hopefully come up again. We have paid a dividend of 3 kroner this year in line with what we have put up as expectation. And you can see in the long run since 2010, we have outperformed the market. And we have also outperformed the market from 16 until 21. But then we have underperformed in 22 and 23. And I think in 24, so far, we are more or less in line with the market. Maybe a little bit better. Next one. We have approximately 4,000 shareholders, and among our largest shareholders, we have ATP, Danish Pension Fund, Lannebo in Sweden, and Odin in Norway. And our largest shareholder is still Sjoe Finance. Hans Sjoe is our chairman, and Sjoe Finance has acquired more shares during the last quarter, and I have also a significant number of shares and if you take the management team as such then we have approximately one third of the shares other Danish investors has one third of the shares and the people or investors from outside Denmark has the last one third of the shares and over the years we've got many more shareholders and we have still room for more next one Well, our customers, they want better and cheaper products. We help them to substitute wood, metal and glass with plastic and composite. We manufacture globally with a powerful team, the right equipment and the right technology. Customers focus on core business and outsource plastic production to specialists and we make a customer solution that gives him lower capex low opex better quality and delivery on time customers want fewer and better suppliers our ambition is to be the preferred supplier so if the customers want to reduce number of suppliers then it is important for us to be one of the few they decide to continue with and then we have the mega trends that is a growing aging population the climate and the scarcity of resources so we have decided to have a strong exposure to growth industries like health care, clean tech and the food industry. And we believe there is a good structural growth in these areas because we're getting more and more people on the planet. We want to live longer. We want to have a healthier life. We want to avoid getting pains. We want to have better foods and better health care when we get old. And in all these industries, you need SB Group's products and competences. Next one. And then we come to the outlook for 2024, and here I will hand over the floor to Lars. Thank you.

Yes, please take the next one, Rasmus. We have had a great first half year and we expect a very exciting second half year of 2024. However, the global economy is still fragile and There is a lot of uncertainty. We also face that very limited growth in Europe. But on the same time, we have developed new products and new solutions for our customers. We have found new customers and we have a great sales team, especially on our own products that have made a very strong execution. So we continue. We expect to see continued growth. We also have the capacity in the factories to produce it. So we have a new guidance. We see that our revenue growth will be in the range of 8 to 18%. Previously, we guided 5 to 15%. We also expect some of the growth will end on the bottom line. We expect now an EBITDA margin of 19 to 21%. Previously, we guided 16 to 19%. And finally, EBT margin in the level of 11 to 13%. Previously, we guided 9 to 12%. Please take the next one, Asmus. We still have a huge focus on sustainability. There is sustainability in everything we do. We have an ambition of achieving zero environmental impact from our operations. Already today, we are powering a lot of the factories with green energy, either on certificates or directly bought on PPA agreements. We are measuring our scope one and two emissions, and we have a target of being carbon neutral in 2030. Furthermore, Yeah, that is the last thing. Last year we had 14 percent of everything that we produced was made by recycled plastics. And that is a process that we continue to develop and find new products where we can use more, you could say, reuse plastics into new products. And we focus on the global UN Sustainable Development Goals, as also mentioned in the annual report. That is an ongoing work for all of us. And of course, plastics should not end up in the environment or in the oceans. To a great extent, the plastic that we produce is mainly components that end up in machines or equipment that is used for many, many years. We are not producing bags or cutlery or straws. And we are very limited within packaging. The packaging that we do is a high-end packaging for medical purposes. So all in all, we believe that we are part of the solution and not the problem.